HOME >> MEDICINE >> NEWS
New treatment boosts muscle function in myasthenia gravis

ST. PAUL, Minn. - A new type of treatment significantly reduces the severity of muscle weakness in myasthenia gravis (MG), giving hope for a new class of drugs to treat neurological disorders, according to a study published in the August 14, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.

The drug, oral EN101antisense, inhibits the production of acetylcholine esterase, which is an important enzyme in the function of the neuromuscular junction, where nerves connect with muscles. Antisense is a synthetic, short segment of DNA that locks onto a strand of mRNA and blocks production of specific proteins.

This is the first time weve been able to show that antisense is effective and safe when taken orally for a neurological disease, said study author Zohar Argov, MD, with Hadassah Hebrew University Medical Center in Jerusalem and member of the American Academy of Neurology. Oral delivery of antisense has long been sought after since it is expected to improve patient compliance because daily injections wont be needed.

People with myasthenia gravis have increased fatigue and reduced strength in their voluntary muscles. Symptoms may also include a drooping eyelid, double vision, difficulty in swallowing, or slurred speech. Myasthenia gravis is believed to affect 20 out of every 100,000 people.

For the study, 16 people with myasthenia gravis were given daily doses of oral EN101 antisense for four days and monitored for one month. Four of the people later took the drug for a month. The study found that oral antisense reduced disease severity by an average of 46 percent, with patients experiencing improved muscle function, improved swallowing time and the disappearance of a drooping eyelid. Side effects reported during the study were dryness of eyes and mouth.

Experts say this discovery may have implications beyond myasthenia gravis. Oral antisense may become another mode of therapy in
'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
13-Aug-2007


Page: 1 2

Related medicine news :

1. Spot on treatment for acne
2. New treatment effective in counteracting cocaine-induced symptoms
3. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
4. Preventive treatments in elderly people needs rethinking
5. Osteoporosis screening and treatment may be cost-effective for selected older men
6. Quality of treatment guidelines
7. Green tea holds promise as new treatment for inflammatory skin diseases
8. Many heart attack patients still not getting emergency clot-busting treatment
9. Electric fields have potential as a cancer treatment
10. New algorithm matches any tumor cells to best possible anti-cancer treatments
11. Screening for behavioral health first step to getting treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/11/2019)... ... 11, 2019 , ... Executives at health systems and hospitals across America are ... over the past several years has been intense. For professionals and organizations that struggle ... America will depend largely on how these executives respond. Will they have the tools ...
(Date:9/11/2019)... ... September 10, 2019 , ... ... facing the ever-changing corporate landscape, Mediaplanet today announces the launch of its ... topics ranging from the importance of candid one-on-one conversations, ideas for improving ...
(Date:9/9/2019)... ... September 09, 2019 , ... ... Dentistry in Cornelius, NC, now welcome individuals with tooth loss in Davidson, NC ... with patients who have single or multiple missing teeth and want the advantages ...
(Date:9/9/2019)... ... September 09, 2019 , ... On September 6, 2019, ... on a diabetes-language movement (#LanguageMatters) to include oral and written language. The organization ... stigma, respectful and inclusive, empowering, and person-centered (to include care that is respectful ...
(Date:9/8/2019)... ... 2019 , ... The Southern Illinois University Edwardsville School of ... reached an all-time high with 1,778 students. , The SON’s enrollment features ... students. The total does not include an additional 30 undeclared graduate students, who ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... ... 14, 2019 , ... On September 11, 2019, after a ... in Middlesex County found Johnson & Johnson liable for causing the Plaintiffs’ cancers. ... by asbestos-containing J&J talc products. , A unanimous jury found that ...
(Date:9/12/2019)... ... September 12, 2019 , ... iPatientCare, a ... practice management, and patient engagement solutions, announced today the participation of Amazon ... (NUCON) 2019 . The annual conference features informative sessions about upcoming enhancements, ...
(Date:9/11/2019)... ... September 12, 2019 , ... Understanding the Drug ... FDAnews Webinar, Thursday, Sept. 26, 2019, 1:30-3:00 p.m. EDT, https://www.fdanews.com/understanding-the-dscsa , ... Is the company clear on nuances of the guidelines regulating the drug supply ...
Breaking Medicine Technology:
Cached News: